Osteogenic sarcoma of the mandible and maxilla

Our early aggressive management of osteogenic sarcoma of the facial skeleton in two patients included the use of radical surgery, irradiation, and chemotherapy. One patient died after two years, but the other patient is alive and free of disease after five years. Despite a better prognosis for osteogenic sarcoma of the facial bones than for osteogenic sarcoma of the long bones, it remains a highly lethal disease with a high local recurrence rate.